I now have comprehensive information from multiple authoritative textbooks (Guyton & Hall, Katzung's Pharmacology, Harrison's, Sleisenger & Fordtran's). Here is a well-structured 5-mark answer:
INR (International Normalized Ratio) and Its Significance
Definition
The International Normalized Ratio (INR) is a standardized measure derived from the Prothrombin Time (PT) that reflects the activity of the extrinsic pathway of coagulation. It was developed to eliminate inter-laboratory variability in PT measurements caused by differences in thromboplastin reagents used across laboratories.
Formula
$$\text{INR} = \left(\frac{\text{PT}\text{patient}}{\text{PT}\text{normal mean}}\right)^{\text{ISI}}$$
- ISI = International Sensitivity Index, assigned by the manufacturer for each batch of tissue factor/thromboplastin; usually ranges between 1.0 and 2.0
- The ISI relates measured prothrombin times to a WHO reference standard thromboplastin, so results from different instruments and reagents yield the same INR for a given sample
(Guyton & Hall Textbook of Medical Physiology; Katzung's Basic and Clinical Pharmacology, 16th ed.)
Normal Values
| Condition | INR Range |
|---|
| Healthy individual | 0.9 – 1.3 |
| Warfarin therapy (most indications) | 2.0 – 3.0 |
| High-risk conditions (e.g., tilting-disk valve) | 2.5 – 3.5 |
| High INR (≥4–5) | Indicates high bleeding risk |
| Low INR (≤0.5) | Suggests increased thrombotic tendency |
Coagulation Factors Assessed
The PT/INR measures the extrinsic pathway of coagulation. Factors assessed include:
- Factor II (Prothrombin)
- Factor V
- Factor VII (shortest half-life: ~6 hours - most sensitive to acute liver failure)
- Factor X
All these factors are synthesized in the liver and require Vitamin K for carboxylation-dependent activation (except Factor V).
Clinical Significance
1. Monitoring Anticoagulation Therapy
- INR is the gold standard for monitoring warfarin (Vitamin K antagonist) therapy
- Warfarin inhibits carboxylation of Factors II, VII, IX, and X
- Target INR: 2.0–3.0 for most indications; titrated with dose adjustments
- Warfarin takes 5–7 days to achieve full effect; bridging with heparin is needed until two sequential INR values are in the therapeutic range
(Harrison's Principles of Internal Medicine, 22nd ed.)
2. Assessment of Liver Synthetic Function
- Since clotting factors are made in the liver, a raised INR reflects impaired hepatic synthetic function
- Factor VII's short half-life makes PT/INR sensitive to acute changes in liver function
- The INR is a component of the MELD score (Model for End-stage Liver Disease), along with serum bilirubin and creatinine, used to prioritize liver transplant allocation
- Caveat: INR may not accurately reflect bleeding risk in cirrhosis, since it only measures procoagulant factors, not anticoagulant proteins (Protein C, antithrombin)
(Sleisenger & Fordtran's Gastrointestinal and Liver Disease)
3. Diagnosis of Coagulopathies
- Prolonged PT/INR can indicate:
- Liver disease (reduced factor synthesis)
- Vitamin K deficiency (IV Vitamin K → ≥30% improvement confirms hypovitaminosis K)
- Disseminated Intravascular Coagulation (DIC) - distinguished by Factor VIII levels (low in DIC, normal/elevated in liver disease)
- Congenital clotting factor deficiency
4. Pre-operative Risk Assessment
- INR is routinely checked preoperatively to assess bleeding risk
- An INR >2.0 in a non-anticoagulated patient signals significant coagulopathy requiring correction before surgery
5. Prognostic Value
- INR has prognostic significance in:
- Acute liver failure (acetaminophen and non-acetaminophen related)
- Alcoholic hepatitis
- Organ transplantation eligibility
Summary Table
| Use | INR Target/Finding |
|---|
| Normal hemostasis | 0.9–1.3 |
| Warfarin (VTE, AF) | 2.0–3.0 |
| Mechanical heart valves | 2.5–3.5 |
| Liver failure indicator | Elevated INR |
| MELD score component | Elevated INR → higher priority |
Key Point: INR standardizes PT across laboratories using the ISI, making it universally comparable. It is indispensable for monitoring anticoagulation, assessing liver function, diagnosing coagulopathies, and determining prognosis in critical illness.